LAT1 Antibody / L-type amino Acid Transporter 1 / SLC7A5 (N-Terminal Region), Rabbit, Polyclonal

Artikelnummer: NSJ-F54110-0.2ML
Artikelname: LAT1 Antibody / L-type amino Acid Transporter 1 / SLC7A5 (N-Terminal Region), Rabbit, Polyclonal
Artikelnummer: NSJ-F54110-0.2ML
Hersteller Artikelnummer: F54110-0.2ML
Alternativnummer: NSJ-F54110-0.2ML
Hersteller: NSJ Bioreagents
Wirt: Rabbit
Kategorie: Antikörper
Applikation: WB
Spezies Reaktivität: Human
Immunogen: A portion of amino acids 15-45 from human LAT1 was used as the immunogen for the LAT1 antibody.
Large neutral amino acids transporter small subunit 1 / LAT1 / SLC7A5 is a sodium-independent, high-affinity transport of large neutral amino acids such as phenylalanine, tyrosine, leucine, arginine and tryptophan, when associated with SLC3A2/4F2hc. Involved in cellular amino acid uptake. Acts as an amino acid exchanger. Involved in the transport of L-DOPA across the blood- brain barrier, and that of thyroid hormones triiodothyronine (T3) and thyroxine (T4) across the cell membrane in tissues such as placenta. Plays a role in neuronal cell proliferation (neurogenesis) in brain. Involved in the uptake of methylmercury (MeHg) when administered as the L-cysteine or D,L-homocysteine complexes, and hence plays a role in metal ion homeostasis and toxicity. Involved in the cellular activity of small molecular weight nitrosothiols, via the stereoselective transport of L- nitrosocysteine (L-CNSO) across the transmembrane. May play an important role in high-grade gliomas. Mediates blood-to-retina L- leucine transport across the inner blood-retinal barrier which in turn may play a key role in maintaining large neutral amino acids as well as neurotransmitters in the neural retina. Acts as the major transporter of tyrosine in fibroblasts. [UniProt]
Klonalität: Polyclonal
UniProt: Q01650
Reinheit: Antigen affinity
Formulierung: In 1X PBS, pH 7.4, with 0.09% sodium azide
Antibody Type: Primary Antibody
Application Verdünnung: WB: 1:2000
Anwendungsbeschreibung: The stated application concentrations are suggested starting points. Titration of the LAT1 antibody may be required due to differences in protocols and secondary/substrate sensitivity.